This upregulation facilitates oncogenic effects through the CCL20/CCR6 signaling axis, which directly facilitates cancer cell migration and proliferation and indirectly promotes cancer progression by recruiting Treg cells expressing high levels of CCR6, thereby fostering the formation of an immunosuppressive TME (48, 56, 57). This evidence concerns the gene CCR6 and cancer.